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ABSTRACT 
Apoptosis is the process of programmed cell death. Increasing knowledge of this 
biological process can lead to understanding of neurodegenerative diseases and cancer 
alike. In mammals, this process occurs through mechanisms that are localized to the 
mitochondria. The release of cytochrome c is from the mitochondrial outer membrane 
(MOM) is regulated by pro and anti-apoptotic Bcl-2 family proteins. If the latter are 
successful, then cytochrome c’s release into the cytosol activates a caspase cascade, 
resulting in apoptosis of the cell. Pro-apoptotic Bax is present in complexes that contain 
voltage dependent anion channels (VDACs). We hypothesized that in healthy cells, 
VDACs act as a restraint by creating a complex in the MOM that interferes with Bax’s 
ability to form pores with Bak.  
Drosophila Melanogaster was used as the genetic platform to create and induce 
mutations in the porin gene. The UAS/GAL4 system is used to target gene expression 
within any tissue of the Drosophila organism. We used transgenic flies using this system 
to enhance the expression of Bax in the eye or wing tissues of the fly. When Bax is 
expressed it induces apoptosis. We also used the CRISPR/Cas9 system to introduce point 
mutations within the BH3 domain of the Drosophila form of VDAC (Porin) to 
investigate the Bax-Porin relationship.  
We then used polymerase chain reaction (PCR) and gel electrophoresis to 
determine the presence of the mutation.  
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Introduction 
 
Apoptotic Outline 
Apoptosis in mammals is programmed cell death. Apoptosis can be used as a regulation 
mechanism to only allow developmentally appropriate and undamaged cells to live and 
proliferate in an effort to maintain homeostasis. Apoptosis is essential to the maintenance 
and development of an organism. Unneeded and damaged cells are disposed of; human 
adults have around 1 to 2 billion cells undergo apoptosis per hour. (Alberts, 2002).  
The intrinsic pathway of apoptosis is initiated by intracellular signals and 
regulated by pro and anti-apoptotic B-cell lymphoma (Bcl-2) family proteins controlling 
the release of mitochondrial intermembrane proteins. Bcl-2 family proteins can have up 
to 4 conserved Bcl-2 homology (BH) domains. These proteins consist of 9 -helical 
strands with similar domains when inactive (Westphal, 2013).  
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Figure 1: Homology Regions of B-cell Lymphoma 2 Family Members. 
Highlighted in differing colors are the conserved BH 1-4 domains of anti and pro 
apoptotic Bcl-2 members. 
  
Illustration from Gross, 1999 
 
 
Anti-apoptotic Bcl-2 genes are considered oncogenes due to their increased 
expression contributing to the characteristic longevity of cancerous cells. (Alberts, 2002). 
Anti-apoptotic Bcl-2 family proteins reside within the cytosolic space as well and inhibit 
apoptosis by binding pro-apoptotic proteins in ways that either prevent them from 
undergoing oligomerization on the surface of the mitochondrial outer membrane (MOM). 
(Alberts, 2002).  
Pro-apoptotic membrane proteins Bak and Bax are BH123 proteins, meaning that 
they have  three of the four conserved BH domains. In mammals, these proteins form the 
oligomers through which the cytochrome c exits the MOM. A distinct difference in these 
family members is that Bak is constitutively present in the MOM while Bax is present in 
the cytosol and is moved to the MOM when signaled. The pro-survival protein Bcl-2 can 
inhibit the proapoptotic proteins Bax/Bak. It is not fully known whether these proteins 
overcome the antagonistic effects of Bcl-2 to induce apoptosis or their activation alone 
induces apoptosis (Figure 2, b). (Gaumer, 2000). 
However, there is another subfamily of pro-apoptotic proteins the BH3-only 
proteins. BH3-only proteins promote apoptosis by binding and neutralizing the anti-
apoptotic Bcl-2 proteins, and by binding to and activating Bax and Bak. The Bax and Bak 
proteins then can form an oligomer on the MOM. The oligomerization of Bax and Bak 
occurs by the exposed BH3 domain of one protein interacting with a groove within the 
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second molecule. These BH3 domain interactions lead to the formation of an oligomer 
that allows the membrane to be permeabilized  (Alberts, 2002; Westphal 2013).   
 
 
 
 
Figure 2: Bcl-2 family interactions.  
(a) Proapoptotic Bax/Bak and BH3 only proteins are shown. Anti-apoptotic Bcl-2 
proteins inhibit the activity of proapoptotic Bcl-2 family members. (b) Apoptosis can be 
inhibited by Bax being bound and brought to the cytosol, BH3 only proteins can be 
inhibited from activating Bax/Bak, or Bax and Bak can be bound to prevent their 
oligomerization. (c) BH3 proteins activate Bax/Bak by directly binding them or 
competing with anti-apoptotic proteins. 
Illustration from Wesphal, 2013 
 
 
The mechanism by which Bax/Bak form a pore on the MOM is unclear, but there 
is evidence that they interact with voltage dependent anion channel (VDAC) 1 and 2 to 
accomplish this. VDAC is an abundant protein on the surface of the mitochondria that 
serves as not only a pore for metabolites but also interacts with pro and anti-apoptotic 
proteins. VDAC2 is thought to enhance recruitment of Bak to the MOM and also keep 
Bak in its inactive state. Many healthy cells have MOM-inserted Bak that is associated 
with VDAC2. Pro-apoptotic Bax is present in complexes that contain VDAC 1 and 2 on 
the MOM in healthy cells. These Bax-VDAC complexes are what we hope to investigate 
further with our research. (Camara 2017; Westphal, 2013).  
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As a result of the Bax/Bak pore formation, cytochrome c is released into the 
cytosol of the cell which leads to the activation of a caspase cascade (Figure 3).  The 
combined loss of functionality of the energy creating pathway of the cell due to the loss 
of the polarization of the membrane needed to power electrochemical gradient is enough 
to cause the cell considerable losses. The release of this material activates a caspase 
cascade to start cell death. The cascade is activated by Cytochrome c binding the 
apoptotic protease activating factor 1 (APAF1) protein which then oligomerizes into an 
apoptosome. Executioner caspases begin in the inactive procaspase phase but are then 
cleaved and therefore activated by an initiator caspase like Caspase-9 (Cas9). The 
cleavage of these executioner caspases induces a cascade of proteolytic cleavage, 
resulting in the breakdown of cellular components. (Alberts, 2002) 
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Figure 3: Apoptotic Pathway Throughout the Cell. The intrinsic apoptosis pathway is 
activated by stimuli such as DNA damage, ischemia, and oxidative stress. Pro-apoptotic 
signaling causes the release of cytochrome c into the cytoplasm. Bcl-2 proteins regulate 
this process at the MOM. When in the cytoplasm, cytochrome c forms an apoptosome 
with apoptotic protease activating factor 1 (APAF1) and the inactive form of caspase-9. 
Cas9 is activated and then cleaves and activates the executioner caspases-3/6/7, resulting 
in cell apoptosis.                                                                                                        
Illustration from Creative Diagnostics 
 
Investigating Bax-VDAC Relationship 
 
 
We hypothesized that in healthy cells, VDAC proteins in the MOM acts as a 
restraint on Bax by creating a Bax-VDAC complex in the MOM that interferes with 
Bax’s ability to oligomerize and form pores.  The absence of activated Bax in Bax-
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VDAC 1 complexes in healthy cells represents that Bax is being prevented from 
prematurely assembling complexes in the MOM. We have recently discovered that the 
VDAC protein appears to have a BH3-like domain on its N-terminus (Figure 4).  We 
would like to investigate this part of the VDAC protein and to determine if the domain is 
an actual BH3 domain where the proteins are interacting.  (Jekabsons and Jones, 2019) 
 
 
Figure 4: Conserved Regions of Bcl-2 Family Members and VDACS. 
Hydrophobic regions H0-5 are shown. The conserved aspartate (D) is in red. It is 
hypothesized that VDAC has a BH3 domain similar to Bcl-2 family proteins. 
Figure from Jekabsons and Jones, 2019 
To investigate the relationship between Bax and VDAC, the model organism of 
Drosophila was chosen because it is well-studied with many tools available to manipulate 
gene expression with. In addition,  Drosophila has Bax and VDAC homologs, and 
mammalian Bax can induce apoptosis when expressed in the compound eyes  or in the 
wings of Drosophila.  Due to the presence of eyes and wings being unessential to the 
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Drosophila’s survival, it is possible to genetically manipulate the components of 
apoptosis in them and evaluate what happens phenotypically.  
The UAS/GAL4 system is used to target gene expression within any tissue of the 
Drosophila organism. GAL4 is a transcription factor found in yeast that encodes a protein 
that will bind to an enhancer called the Upstream Activating Sequence (UAS) to activate 
gene expression.  Under the control of tissue specific enhancers GAL4 can be expressed 
in Drosophila  target organs such as the eyes or wings of a fly. The exogenous yeast 
GAL4 is used because it has no endogenous targets within Drosophila DNA, meaning 
that it does not affect gene expression without UAS and its target gene present. However 
if yeast enhancer UAS is present, it acts as an upstream activating sequence when its 
GAL4 binding sites are bound and activates expression of the target gene. This system is 
turned on when a fly with GAL4 expressed in particular cells is crossed with another fly 
containing UAS-Bax (Figure 5) for example. (Brand, 1993).  
The GMR-GAL4 line is expressed in the eye and was crossed with UAS-Bax to 
generate offspring with GMR-GAL4; UAS-Bax. This turns on the expression of the Bax 
gene in the eye which creates more pro-apoptotic proteins and results in a rough 
appearance of the eye (Figure 5, B).  It is unknown why the occurrence of apoptosis is 
increased with higher expression of Bax. The Bax protein is lethal and requires activation 
by interacting with other proteins in the MOM. 
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Figure 5: Phenotypes of Transgenic Flies 
(A) A picture of a fly’s eye with UAS-Bax, but no GMR-GAL4 genomic enhancer 
activating its expression. (B) A picture of a transgenic fly’s eye with a rough 
appearance due to tissue-specific increased cell death. This is activated by 
increased Bax expression due to the UAS/GAL4 systems presence. (C) A picture 
of a fly’s wings with UAS-Bax, but no tissue specific vg-GAL4 genomic 
enhancer activating its expression. (D) A picture of a fly’s wings after increasing 
tissue-specific expression of the Bax gene. (E), (F), and (G) show the phenotypic 
variation of flies more weakly expressing the Bax gene when compared to (D) 
Figure  from Jekabsons and Jones, 2019 
 
 
To test for interactions between Porin and Bax the CRISPR/Cas9 system was used 
to introduce point mutations within the BH3 domain of the Drosophila form of VDAC 
(Porin). After the porin gene was mutated, we planned to cross UAS-Bax with GMR-
GAL4 in flies with the porin mutation to see how this would affect the phenotypes. If 
Porin is required for Bax functions, then we should see a phenotypic change with 
mutations in the porin gene. The eyes of the fly could be rougher or get better depending 
on the function of Porin in the enhancement or suppression of the Bax protein’s function.  
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Clustered regularly interspaced short palindromic repeats (CRISPR) allow genetic 
modification to be done in a precise manner. Breaking the DNA in this way allows for 
repair either by nonhomologous end joining (NHEJ) or homology-direct repair (HDR) 
that can be used to edit the genome. This process needs guide RNA (gRNA) that is 
complementary to the Porin gene to indicate where the break will be on the second 
chromosome. The Cas9 protein is directed by a gRNA to cause a double strand cleavage 
of DNA in a specific spot. At the cut site, specific ssDNA or dsDNA repair templates that 
are homologous to the end of the double strand break can be used to start HDR rather 
than NHEJ. Ideally, the cell will find this copy with the new allele that is being 
introduced and use it for a template for DNA repair. This system will be used to cut and 
introduce mutations within the Porin gene.  
 
 
Figure 6:  Required Components for CRISPR and NHEJ vs. HDR. The Cas9 protein 
as well as a gRNA are the basic components for the CRISPR/Cas9 system. This system 
induces a DSB that can be repaired in one of two ways: NHEJ or HDR which are 
pictured here. It was our goal to create a system that would use the HDR method of repair 
to incorporate Porin mutations into the genome. 
Illustration from addgene 
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Included in the plasmid that we used to create the gRNAs for the CRISPR/Cas9 
system is a strong U6:3 promoter for RNA polymerase III which drives ubiquitous 
expression of RNA genes without incorporating a poly-A tail and a cap which we did not 
want added. The plasmid will be cut with Bbs1 and the DNA with the target sequence 
will be inserted within the Bbs1 spacer region. The plasmid containing must then be 
injected along with the oligonucleotide necessary for HDR into fly embryos that express 
Cas9; the plasmid is transcribed to generate multiple gRNAs The single-stranded donor 
oligonucleotide (ssODN) injected has all of the mutations within it and is used to repair 
the DSB caused by Cas9. The Cas9 protein is only present in the germ line cells, because 
we do not want cutting induced in adult flies, we just want the system to alter the DNA of 
cells becoming eggs and sperm. (Gratz 2015).  
Much of the barrel-shaped Porin protein is unaltered, but the BH3-like domain of 
the protein that we hypothesize to interact with Bax is being mutated. One of the point 
mutations we are trying to introduce into the Porin gene using CRISPR changes a 
conserved, negatively charged aspartic acid (D) to an uncharged glycine. The second is a 
point mutation of the BH3 domain’s hydrophobic amino acid side chain leucine (L) to a 
glycine (G).  These mutations would change some of the protein’s highly conserved 
amino acids within its domain and possibly cause the protein to be unable to form the 
Bax-VDAC complex. (Jekabsons and Jones. 2019). 
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Figure 7: Region of Porin BH3 Domain Mutations. The red region of DNA is 
our target gene and underneath is the gRNA target. In the magenta regions, a 
hydrophobic Leucine amino acid will have its codon changed from TTG to GGG so that 
it will now have a Glycine side chain. The other magenta region is changing a charged 
Aspartic Acid codon from GAC to GGC so that it will have a Glycine side chain as well. 
The PAM region is highlighted in blue. The corresponding point mutation before it was 
placed there so that after repair, Cas9 won’t come back and cut there again because the 
gRNA will not line up. 
Illustration by Dr. Brad Jones 
 
 
To see if the system we have introduced has successfully incorporated the 
nucleotide changes from the injected oligonucleotide into the genomic DNA at the porin 
locus, we must screen through fly lines derived from the injected fly embryos. To detect 
flies that have the incorpaorated mutations, the ssODN would also introduce a unique 
restriction site for the enzyme DraI (Figure 7).  This restriction site  will allow DraI to cut 
the DNA fragment generated by PCR into two smaller fragments resulting in two regions 
of DNA at lower weights showing up on an agarose gel. One section will be 362 base 
pairs (bp) while the other will be 763 bps.  
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Materials and Methods 
 
Testing Procedures 
Fly Preparations 
To ensure that the target genotype had been obtained, F1 flies derived from the 
injected embryos were tested. 1 to 10 Drosophila were selected from each line and put 
into an Eppendorf tube, then placed into an -80 C freezer for 5 minutes. Once frozen, 
100 l of Buffer A (100mM TRIS, 100mM EDTA, 100mM NaCl , 0.5% SDS) was 
pipetted into the tube and the flies were homogenized using a mini-pestle. This step is 
essential to break apart and dissolve the cell components that encase the DNA, making it 
available for use. After homogenization, an additional 100 l of Buffer A was pipetted 
into the tube and it was put into a 65 C incubator for 20 minutes. This allowed the 
protein contents of the fly to further breakdown. 40 l of 1.5M K acetate 4.5M LiCl was 
added to the solution as it rested on ice for 20 minutes. The 1.5M K acetate 4.5M LiCl 
solution was used to make the proteins insoluble, detergents, and other smaller cellular 
components insoluble to water.  The mixture was then centrifuged for 15 minutes at 
13,000 RPM. The insoluble cellular components were pelleted at the bottom of the tube 
while the DNA remained soluble. The DNA-containing supernatant was obtained by 
pipetting 100 l from the top of the tube and placing it into a new one. The precipitation 
process was done by adding 200 l of EtOH to the supernatant and then spinning it again 
in the centrifuge at 13,000 RPM for 15 minutes. The negatively charged backbone of the 
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DNA is ionically bound to the positive ions, causing its precipitation from the aqueous 
solution. The supernatant was discarded and the desired outcome of this process is a 
pellet of DNA at the bottom of the tube. The DNA pellet was rinsed to remove unbound 
salt ions by using 200 l of 70% EtOH. Once the remaining ethanol had evaporated and 
the pellet was dry, the DNA was resuspended in 50 l TE solution.  
 
Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) was used to amplify the 1125 bp DNA 
sequence that was edited to determine if the CRISPR/Cas9 system had successfully 
introduced point mutations into the Drosophila genome.  A PCR mix containing 25 l of 
5’ primer, 25 l of 3’ primer, 25 l of PCR Buffer, 25 l of 2 mM dNTPs, and 135 mL 
diH2O was used. Each PCR tube had 23.5 l of PCR mix, 1.0 l of the template DNA 
diluted 1:10 in H2O, and 0.5 l TAQ polymerase. A specific program was used with the 
following temperature and time cycles: 
 
Step # Temperature (C) Time (sec) 
1 94 300 
2 94 30 
3 62 30 
4 72 120 
5 Go to step 2, 34 times -- 
Step # Temperature (C) Time (sec) 
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6 72 420 
7 4 -- 
Table 1: PCR Setup. 
 
The plasmids were designed so that if the mutated sequence was incorporated via 
CRISPR/Cas9, there would be a specific enzyme cut site that is flanked by the primers 
added. The restriction enzyme DraI was used to cut at this specific place in the DNA.  0.5 
µl of DraI enzyme (New England Biolabs) was added to each PCR tube and incubated at 
37 C. .  
 
Gel Electrophoresis 
Gel electrophoresis separates DNA based upon its number of base pairs affecting 
its speed; the shorter a DNA fragment is the faster it will travel. The negative DNA 
travels across the agarose gel towards the positively charged electrode and way from the 
negatively charged electrode. To create the gel, 1.5 grams of agarose per 100 ml Tris-
Acetate-EDTA (TAE) were dissolved by heating, then 0.75 l EtBr were added. The 
DNA ladder was prepared by pipetting 10 l of pre-prepared 1:10 Kb ladder with loading 
dye into the first well of the gel. The samples were prepared by pipetting 1 l of PCR 
product, 1 l gel loading dye, and 8 l of water into a tube and then into their respective 
wells within the agarose gel. 120 volts were applied to facilitate the movement of DNA. 
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Results 
 
The tasks that I was doing in lab were in preparation to screen through the lines 
that had been injected to see if the CRISPR/Cas9 mutations had been integrated into the 
fly’s genome. I needed to be able to consistently and reproducibly carry out fly preps and 
then PCR to get results. I was using multiple fly lines and doing preps of different 
dilutions of flies. The number of flies differed so that when we were testing later, I could 
reliably achieve results with multiple flies so that we could ascertain the frequency of the 
mutation in the F1 generation.  I was able to successfully preform the protocol and obtain 
PCR bands on an agarose gel.  
   1   2    3   4   5   6    7   8   9  10  11  12  13  14 
 
Figure 8: PCR of fly preps with multiple dilutions. Lanes 1 and 14 contain 1 Kb ladder 
solution. Lanes 2-6 are undiluted. Lane 2 contains porin gRNA #1 and lane 3 contains 
porin gRNA #2. Lane 4 contained 1 fly (nos-cas9). Lane 5 contained 5 flies (nos-cas9). 
Lane 6 contains 10 flies (nos-cas9). Lanes 7-13 are diluted. Lane 7 contains w1118 1:10. 
Lane 8 contains 1:10 diluted porin gRNA #1 and lane 9 contains 1:10 diluted porin 
gRNA #2. Lane 10 contains 1:10 dilution with 1 fly. Lane 11 contains 1:10 dilution with 
5 flies. Lane 12 contains a 1:10 dilution with 10 flies. Lane 13 contains w1118 diluted 1:10. 
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Discussion 
 
The results I have yet to obtain were going to be screenings of the injected fly 
lines. The international COVID-19 crisis has made this impossible to do before the 
semester is over because of precautions taken by the University in suspending all 
physical classes and moving to an online format. Dr. Jones had injected GMR-GAL4 and 
UAS-Bax fly embryos with the material for CRISPR/Cas9 system. The lines were then 
crossed to produce progeny with the GAL4/UAS induced over-expression of Bax and 
CRISPR/Cas9 system mutated Porin. It would then be my responsibility to screen 
through the offspring to see if any of the progeny had successfully integrated the 
mutations into their genome. The screening would be done by obtaining DNA from each 
fly line and using PCR to multiply the porin gene and gel electrophoresis to see the 
resulting weights of the DNA. 
The 1125 bp sequence that would be replicated with PCR is shown in figure 9. 
The sequence starts with the blue region representing the 5’ primer and ends with the 
green region representing the 3’ primer. The introduced mutations are in closer to the 
middle of the sequence. The DraI cut site is around 360 bp and highlighted in pink, 
showing where the DNA will be cut if the mutation is successfully incorporated.   
If the CRISPR/Cas9 system had incorporated itself into the DNA, the restriction 
enzyme DraI would cut the DNA at the cut site. The result of this would be that two 
smaller bands of DNA would appear on the gel electrophoresis if a homozygous mutation 
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had occurred. One band would be around 360 bp while the other around 760 bp. The 
mutation is likely to be heterozygous, meaning that a larger and brighter band would be 
seen on the gel at around 1125 bp but then the two smaller bands would also be more 
faintly present. A goal of our experiment was to test the genetic lines to see if they had 
successfully integrated the CRISPR/Cas9 system. 
 
 
Figure 9: Region of porin Gene Replicated with PCR. The region of the porin gene 
that was multiplied using PCR techniques. 
Illustration by Dr. Brad Jones 
 
Our hope in screening the 20 lines that were injected is that at least one would 
have the incorporated mutation.  Unfortunately, our research ended promptly in March 
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not allowing me to get past the preparation phase for this experiment. If continued, lines 
with mutations detected would be crossed and screened through continually with the goal 
of increasing the number of flies with the mutation. Eventually, we would hopefully have 
fly lines that were homozygous with the inserted mutation.  
 
 
 
 
 
 
 
  
.  
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